ABPI response to publication of the Government's consultation on value based pricing

 
Dr Richard Barker, Director General of the Association of the British Pharmaceutical Industry, said:

“We welcome the publication of the Government’s consultation on value based pricing and look forward to representing the pharmaceutical industry in co-creating the new system with Government. As Government has said, the priority in any new system must be rapid and consistent patient access to new medicines - value is meaningless without consistent access. Any new system must also fairly recognise and reward innovation and investment in research and development. The UK continues to lag behind Europe in the uptake of innovative medicines despite having amongst the lowest prices, so price alone is clearly not the main driver of access in the NHS. But we agree fully that the Government and the NHS should seek value for money from medicines, and expect NICE to continue to play a key part in the process. Our industry must demonstrate the full value of its medicines, it is for Government to put in place processes which assess that full value, and then secure access to that value for NHS patients.”
 
Print this page icon Print this page
 
Please choose the subject of your enquiry from the list below:
 
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.